Companies similar to OCULAR THERAPEUTIX INC (OCUL)

Health Care · NASDAQ

OCULAR THERAPEUTIX INC (OCUL)'s closest peers include Regeneron Pharmaceuticals (REGN), NOVARTIS AG (NVS) and AbbVie (ABBV). This peer set is drawn from OCUL's enriched company profile and is informational only — not financial advice.

Similar companies

• Regeneron PharmaceuticalsREGNHealth Care

  Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…

  $675.19 (as of 2026-07-21) · market cap $69.9B

• NOVARTIS AGNVS

  Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.

  $153.87 (as of 2026-07-21) · market cap $228.2B

• AbbVieABBVHealth Care

  Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.

  $256.10 (as of 2026-07-21) · market cap $447.7B

Not quite? Describe exactly what you want →

Peers are drawn from OCUL's enriched profile (the same similarity signal the chat uses for "companies like OCUL"). See the full profile: OCULAR THERAPEUTIX INC (OCUL).

Last updated 2026-07-21.

Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.